You are on page 1of 2

Clinical Review & Education

JAMA Insights | CLIMATE CHANGE AND HEALTH

Infectious Diseases in a Changing Climate


Matthew C. Phillips, MD, PhD; Regina C. LaRocque, MD, MPH; George R. Thompson III, MD

Climate change is happening now. Nine of the 10 hottest years on associated illnesses reported to the US Centers for Disease Control
record have occurred in the past decade and were accompanied by and Prevention more than doubled, to a total of more than 760 000
extreme heat waves, droughts, wildfires, hurricanes, and severe cases. Multiple pathogens, including West Nile, Powassan, and Zika
flooding. Primarily due to greenhouse gases released via combus- viruses, have been identified that were not previously seen or com-
tion of fossil fuels, global aver- mon in the US.2 This increase may be related to improved aware-
age temperatures between 2011 ness, diagnostic methods, and case reporting, but climate-related
CME at jamacmelookup.com
and 2020 increased to 1.1 °C changes in vector biology are also contributing. For instance, tick
(approximately 1.9 °F) above preindustrial levels and are estimated survival over winter months increases with shorter, milder winters,
to increase to 1.5 °C (approximately 2.7 °F) by 2040.1 leading to larger populations and northern extension of their geo-
Local manifestations of the warming earth, such as shorter graphic locations into Canada and the upper Midwest US. Longer sum-
winters, changes in precipitation, and increased frequency of ex- mers result in more months per year when ticks bite, creating more
treme weather events, will cause worldwide changes in patho- opportunities to spread diseases such as babesiosis, anaplasmosis,
gens, vectors, and the behavior of animal reservoirs and people. and Lyme disease. Mosquitoes have a short lifespan and respond rap-
These changes may alter infectious disease epidemiology in the US idly to changes in weather. Mosquitoes require water to breed, and
and internationally as traditionally accepted regions of disease ac- changes in precipitation can significantly alter the size and location
quisition lose relevance, seasonal associations change, and new of local mosquito populations. Warmer temperatures increase effi-
pathogens emerge. Awareness of changes in the geographic range, ciency of the mosquito breeding cycle, leading females to require
seasonality, and frequency of transmission of infectious diseases be- more blood meals to support multiple gestations over their lifetime.3
cause of climate change is important to help clinicians diagnose, treat, Higher temperatures have promoted northern extension of loca-
and prevent infectious diseases in patients (Table). tions of pathogen-carrying mosquito species such as Aedes aegypti,
the primary vector for dengue, chikungunya, yellow fever, and Zika.
Vector-Borne Diseases Some of these diseases are now locally transmitted in the US, pri-
In the US, climate change is altering environmental conditions and marily in southern states such as Florida and Texas.3 Malaria, trans-
facilitating proliferation of arthropod disease vectors such as ticks and mitted by Anopheles mosquitoes, also increased during the sum-
mosquitoes. Between 2004 and 2018, the number of arthropod- mer of 2023 with several locally acquired cases reported in the US.4

Table. Impact of Climate-Related Changes on Infectious Disease Epidemiology


Effect on infectious disease
Disease type Climate-related change epidemiology Examples
Vector-borne Shorter, warmer winters Increased disease incidence Babesiosis
diseases Longer summers Expanding seasonality into winter Lyme disease
Expanding range of vectors, eg, mosquitoes and ticks months Anaplasmosis
Changes in precipitation patterns Expanding geographic range, primarily Powassan virus
northward and westward
Ehrlichiosis
Increased likelihood of onward
transmission Dengue
Zika virus
Chikungunya virus
Malaria
Zoonotic Changes in animal migration patterns, natural ranges, Increased cross-species transmission Avian influenza (H5N1)
diseases and population density events Plague
Habitat destruction Emergence of novel human pathogens Hantavirus
Increased interaction between different animal species Increased disease incidence Tularemia
Increased human-animal interaction Expanding geographic range Emerging coronaviruses
Fungal diseases Expanded thermotolerance in fungal organisms Emergence of novel human pathogens Candida auris
New favorable environments for endemic fungi Expanding geographic range of endemic Sporothrix brasiliensis
mycoses Coccidioides
Histoplasma
Blastomyces
Waterborne Rise of sea level Increased disease incidence after storms Campylobacter
diseases Extreme weather events Expanding seasonality Escherichia coli
Flooding-induced strain on water infrastructure Expanding geographic range, primarily Cryptosporidium
Changes in precipitation patterns northward Vibrio species
Changes in coastal water temperature

jama.com (Reprinted) JAMA Published online March 20, 2024 E1

© 2024 American Medical Association. All rights reserved.


Clinical Review & Education JAMA Insights

Zoonotic Diseases saprophytic organism dwelling on plant material to a zoonotic dis-


Zoonotic infections are infections that spread between humans and ease supported by growth at higher temperature. Endemic fungi
other vertebrate animals and may be viral, bacterial, or parasitic. Cli- have been located outside of their traditionally described geo-
mate change alters population dynamics and behaviors of host ani- graphic locations. Coccidioides is expanding to northern and east-
mals, which can increase zoonotic disease spread. In the western US, ern locations, with cases recently identified in Nebraska; Histo-
changes in precipitation and temperature affect food availability, plasma has been documented in more Northern and Eastern
population size, and behavior of rodent hosts for plague and han- locations, including Alberta, Minnesota, and Wisconsin; and Blasto-
tavirus. These changes result in increased disease incidence and a myces has moved westward, with a novel species (B helicus) now
geographical shift northward and to higher altitudes.5 Models esti- seen in the Rocky Mountain region.9
mate that more than half of the earth’s animal species are experi-
encing climate-induced alterations of their natural ranges, with many Waterborne Diseases
moving northward as habitat suitability declines in the global south.6 Sea level rise is inevitable, directly influencing the approximately 40%
Habitat destruction leads to numerous species coming into close con- of individuals in the US who live in coastal counties. Extreme “once-
tact, increasing the risk of pathogens (particularly viruses) spread- per-century” sea level events, such as storm surges and coastal flood-
ing to other species, potentially including humans. Migratory birds ing, are anticipated to occur 20 to 30 times more frequently by 2050.1
are uniquely affected by habitat destruction and have been the pri- These events, combined with warming, increase contact with coastal
mary cause of the current global outbreak of avian influenza (H5N1). pathogens (eg, Vibrio species), which can cause gastroenteritis, soft
Since January 2022, H5N1 has been detected in all 50 US states, in tissue infections, and sepsis, with mortality rates of up to 50%. Within
more than 7500 birds, and has promoted interspecies transmis- 2 weeks of Hurricane Ian making landfall in 2022 in Florida, 38 cases
sion in multiple mammalian species.7 Transmission of zoonotic dis- of vibriosis had been diagnosed, leading to 36 hospitalizations and 11
eases are increased by globalization; changes in land use, such as deaths.10 While typically associated with southern coastlines, cases of
deforestation; and human migration, including international travel. V vulnificus have increased in mid-Atlantic states in association with
rising ocean temperatures.3 Other waterborne pathogens, such as
Fungal Diseases Campylobacter, Escherichia coli, and Cryptosporidium, cause diar-
Fungi are soil-dwelling pathogens and, although there are more rheal disease after flooding and are worsening with extreme weather
than 1 million recognized species of fungi, only approximately 300 events and warmer climates.3
infect humans. Human body temperature is one of the primary
resistance barriers to fungal pathogens, because most are unable Conclusions
to grow at elevated temperatures.8 However, as these fungal Thoughtful preparation for current and future changes in infec-
organisms develop tolerance to the warming environment, the tious disease epidemiology can help decrease the health effects of
temperature differential between humans and the environment these diseases. Medical education should train clinicians to antici-
narrows and the number of fungal infections, and new pathogens, pate these changes, and an effective surveillance infrastructure is
may increase. Candida auris and Sporothrix brasiliensis may be early needed to understand, measure, and manage climate-related epi-
examples of this phenomenon. C auris was first isolated in 2009 demiologic shifts. Clinicians also have a responsibility to advocate
and has emerged as a significant, and often antifungal-resistant, for policies aimed at ending fossil fuel dependence to mitigate the
global pathogen. S brasiliensis appears to have transitioned from a effects of climate change on human health.

ARTICLE INFORMATION REFERENCES 6. Carlson CJ, Albery GF, Merow C, et al. Climate
Author Affiliations: Division of Infectious Diseases, 1. Climate Change 2023: Synthesis Report. change increases cross-species viral transmission
Department of Medicine, Massachusetts General Intergovernmental Panel on Climate Change; risk. Nature. 2022;607(7919):555-562. doi:10.
Hospital, Boston (Phillips, LaRocque); Harvard Medical 2023:184. 1038/s41586-022-04788-w
School, Boston, Massachusetts (Phillips, LaRocque); 2. Centers for Disease Control and Prevention. 7. Centers for Disease Control and Prevention.
Division of Infectious Diseases, Department of Climate change and infectious diseases. Accessed Technical report: highly pathogenic avian influenza
Medicine, University of California-Davis Medical July 30, 2023. https://www.cdc.gov/ncezid/what- A(H5N1) viruses. Updated October 27, 2023.
Center, Sacramento (Thompson); Department of we-do/climate-change-and-infectious-diseases/ Accessed November 30, 2023. https://www.cdc.
Medical Microbiology and Immunology, University index.html gov/flu/avianflu/spotlights/2022-2023/h5n1-
of California-Davis (Thompson). technical-report_october.htm
3. Edelson PJ, Harold R, Ackelsberg J, et al. Climate
Corresponding Author: G. R. Thompson III, MD, change and the epidemiology of infectious diseases 8. Robert VA, Casadevall A. Vertebrate
Department of Medicine, Division of Infectious in the United States. Clin Infect Dis. 2023;76(5): endothermy restricts most fungi as potential
Diseases/Department of Medical Microbiology and 950-956. doi:10.1093/cid/ciac697 pathogens. J Infect Dis. 2009;200(10):1623-1626.
Immunology, University of California–Davis Medical doi:10.1086/644642
Center, 4150 V St, PSSB Suite G500, Sacramento, 4. Centers for Disease Control and Prevention.
Locally acquired malaria cases identified in the 9. Thompson GR III, Chiller TM. Endemic mycoses:
CA 95817 (grthompson@ucdavis.edu). underdiagnosed and underreported. Ann Intern Med.
United States. June 26, 2023. Accessed August 7,
Published Online: March 20, 2024. 2023. https://emergency.cdc.gov/han/2023/ 2022;175(12):1759-1760. doi:10.7326/M22-2371
doi:10.1001/jama.2023.27724 han00494.asp 10. Sodders N, Stockdale K, Baker K, et al. Notes
Conflict of Interest Disclosures: Dr Phillips 5. Rupasinghe R, Chomel BB, Martínez-López B. from the field: vibriosis cases associated with flood
reported receiving support from NIH T32 Climate change and zoonoses: a review of the waters during and after Hurricane Ian: Florida,
AI007061. Dr LaRocque reported being a board current status, knowledge gaps, and future trends. September-October 2022. MMWR Morb Mortal
member of the Greater Boston Physicians for Social Acta Trop. 2022;226:106225. doi:10.1016/j. Wkly Rep. 2023;72(18):497-498. doi:10.15585/
Responsibility. Dr Thomspon reported receiving actatropica.2021.106225 mmwr.mm7218a5
support from NIH award 5U19AI166798.

E2 JAMA Published online March 20, 2024 (Reprinted) jama.com

© 2024 American Medical Association. All rights reserved.

You might also like